Classic pathway persistent complement activation is associated with specific symptoms in individuals with

César Fernández-de-Las-Peñas1, Maria Ruiz-Ruigómez2, Laura Esparcia-Pinedo3

  • 1Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid, Spain; Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.

Insights

This study found no overall complement activation in COVID-19 survivors with post-COVID-19 condition. However, specific symptoms like fatigue and dyspnea were linked to lower levels of certain complement proteins.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • The complement system is a key immune component, but its role in post-COVID-19 condition remains unclear.
  • Investigating complement activation may offer insights into the pathophysiology of long-term COVID-19 symptoms.

Purpose of the Study:

  • To investigate long-lasting complement hyperactivation in COVID-19 survivors with and without post-COVID-19 condition.
  • To determine if complement pathway activation is associated with the presence of specific post-COVID-19 symptoms.

Main Methods:

  • A case-control study (2:1 design) compared COVID-19 survivors with and without post-COVID-19 condition.
  • Blood samples were analyzed for classical complement pathway proteins (C3, C4, C5, C7) and total hemolytic complement (CH50) activity.
  • Post-COVID-19 condition was defined by self-reported symptoms including fatigue, arthralgia, myalgia, memory problems, headache, or palpitations.

Main Results:

  • No significant differences in overall complement protein levels or CH50 activity were found between groups.
  • Patients with post-COVID fatigue showed lower C3 levels compared to those without fatigue.
  • Survivors with post-COVID dyspnea exhibited lower levels of C3, C5, and C7 proteins.

Conclusions:

  • This study did not find evidence of overall classical complement pathway activation in COVID-19 survivors with post-COVID-19 condition up to two years post-infection.
  • Specific complement proteins were associated with particular post-COVID-19 symptoms, suggesting a nuanced role in the condition.
Abstract

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
542
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
59.0K